RxDoctor Payments Data

Joseph Bessler, MD

Internal Medicine · Lancaster, VANPI 1306850276

Payments from drug & device makers

$1,011in general payments, 2019–2025

Across 63 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$252
  • Abbott$170
  • AbbVie$139
  • GSK$90
  • Johnson & Johnson$62
  • Novo Nordisk$50
  • plus $247 from 9 others

What the payments were for

  • Food & beverage$1,011100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,011 in reported general payments places this provider in the 75th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$2,004
Medicare patients
31
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban273$248,362
OzempicSemaglutide129$164,781
XareltoRivaroxaban50$66,675
TrulicityDulaglutide64$66,348
Teriparatide25$57,262
FarxigaDapagliflozin Propanediol31$31,064
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$21,486
JardianceEmpagliflozin12$16,935
ShingrixVaricella-Zoster Ge/As01b/Pf74$15,480
EntrestoSacubitril/Valsartan23$15,298
Combivent RespimatIpratropium/Albuterol Sulfate25$11,707
Olmesartan Medoxomil446$10,078
BrilintaTicagrelor18$7,894
Telmisartan-AmlodipineTelmisartan/Amlodipine26$5,940
Atorvastatin Calcium392$3,855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$48$248,362273 claims
Novo NordiskOzempic$50$164,781129 claims
Johnson & JohnsonXarelto$62$66,67550 claims
AstraZenecaFarxiga, Brilinta$252$38,95849 claims
GSKTrelegy Ellipta, Shingrix$90$36,966100 claims
Boehringer IngelheimJardiance, Combivent Respimat$16$28,64237 claims
AbbVieSynthroid$139$2,62359 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 internal medicine providers in Virginia.

Other internal medicine in Lancaster

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →